Indication
Meningeal Metastasis
1 clinical trial
1 product
Clinical trial
A Retrospective Study of the Efficacy and Safety of Lolatinib in Anaplastic Lymphoma Kinase (ALK) - Positive Non-Small Cell Lung Cancer (NSCLC) Patients With Brain or Meningeal MetastasisStatus: Active (not recruiting), Estimated PCD: 2024-03-31
Product
Lorlatinib